These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 13410650)

  • 21. Age-at-exposure effects on risk estimates for non-cancer mortality in the Japanese atomic bomb survivors.
    Zhang W; Muirhead CR; Hunter N
    J Radiol Prot; 2005 Dec; 25(4):393-404. PubMed ID: 16340068
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Signe visited Hiroshima and Nagasaki after the atom bomb: "What I saw and heard then was the biggest shock". Interview by Jan Thomasson].
    Höjer S
    Vardfacket; 1982 Sep; 6(17):9-10. PubMed ID: 6924527
    [No Abstract]   [Full Text] [Related]  

  • 23. The long-term outcome of atomic bomb survivors with gastric carcinoma.
    Yamamoto M; Matsuyama A; Kameyama T; Okamoto M; Okazaki J; Utsunomiya T; Tsutsui S; Ishida T
    J Surg Oncol; 2009 Dec; 100(7):594-7. PubMed ID: 19731244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of Sjogren syndrome among Nagasaki atomic bomb survivors.
    Hida A; Akahoshi M; Takagi Y; Ashizawa K; Imaizumi M; Soda M; Maeda R; Nakashima E; Ida H; Kawakami A; Nakamura T; Eguchi K
    Ann Rheum Dis; 2008 May; 67(5):689-95. PubMed ID: 17905783
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of atherosclerosis in relation to atomic bomb radiation exposure: an RERF Adult Health Study.
    Yamada M; Naito K; Kasagi F; Masunari N; Suzuki G
    Int J Radiat Biol; 2005 Nov; 81(11):821-6. PubMed ID: 16484151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoplasms among A-bomb survivors in Hiroshima: first report of the Research Committee on Tumor Statistics, Hiroshima City Medical Association, Hiroshima, Japan.
    HARADA T; ISHIDA MI
    J Natl Cancer Inst; 1960 Dec; 25():1253-64. PubMed ID: 13711417
    [No Abstract]   [Full Text] [Related]  

  • 27. Nature Immersion in an Extreme Environment: Hiroshima Survivors' Personal Emergence Following Their Atomic Bomb Experience.
    Nagata M; Ito M; Takahashi R; Nishimura C; Liehr P
    Int J Environ Res Public Health; 2022 Nov; 19(23):. PubMed ID: 36497967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Survivors of bombing of Hiroshima 3 years later.
    NOVY FG
    Arch Derm Syphilol; 1950 Mar; 61(3):379-83. PubMed ID: 15404850
    [No Abstract]   [Full Text] [Related]  

  • 29. Hematologic findings in children exposed to A-bomb radiation in utero in Hiroshima.
    TAKAMURA T; UEDA S
    Blood; 1961 Jun; 17():728-37. PubMed ID: 13774930
    [No Abstract]   [Full Text] [Related]  

  • 30. [Number of casualties and extent of damage after the atomic bombings of Hiroshima and Nagasaki].
    KEIM H
    Strahlentherapie; 1959 Apr; 108(4):594-601. PubMed ID: 13668792
    [No Abstract]   [Full Text] [Related]  

  • 31. Atomic bomb injuries among survivors in Hiroshima.
    REYNOLDS ML; LYNCH FX
    Public Health Rep (1896); 1955 Mar; 70(3):261-70. PubMed ID: 14357547
    [No Abstract]   [Full Text] [Related]  

  • 32. Rays as weapons.
    Vogel H
    Eur J Radiol; 2007 Aug; 63(2):167-77. PubMed ID: 17630244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hematological data on atomic explosions].
    LEITE G
    Rev Bras Med; 1956 Sep; 13(9):699-700. PubMed ID: 13389938
    [No Abstract]   [Full Text] [Related]  

  • 34. Systolic blood pressure and systolic hypertension in adolescence of atomic bomb survivors exposed in utero.
    Nakashima E; Akahoshi M; Neriishi K; Fujiwara S
    Radiat Res; 2007 Nov; 168(5):593-9. PubMed ID: 17973553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The physical growth and development of children who survived the atomic bombing of Hiroshima or Nagasaki.
    GREULICH WW; CRISMON CS; TURNER ML
    J Pediatr; 1953 Aug; 43(2):121-45. PubMed ID: 13070125
    [No Abstract]   [Full Text] [Related]  

  • 36. Current risk estimates based on the A-bomb survivors data - a discussion in terms of the ICRP recommendations on the neutron weighting factor.
    Rühm W; Walsh L
    Radiat Prot Dosimetry; 2007; 126(1-4):423-31. PubMed ID: 17533156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The survivors of Hiroshima and Nagasaki: delayed effects.
    Hollingsworth JW
    West J Med; 1983 Feb; 138(2):219-21. PubMed ID: 6837024
    [No Abstract]   [Full Text] [Related]  

  • 38. Cataract in atomic bomb survivors.
    Minamoto A; Taniguchi H; Yoshitani N; Mukai S; Yokoyama T; Kumagami T; Tsuda Y; Mishima HK; Amemiya T; Nakashima E; Neriishi K; Hida A; Fujiwara S; Suzuki G; Akahoshi M
    Int J Radiat Biol; 2004 May; 80(5):339-45. PubMed ID: 15223766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Damages caused by secondary effects of radiation and the dosimetric problem of residual activity in the atom-bombed cities of Hiroshima and Nagasaki].
    GOMER JJ
    Strahlentherapie; 1959 Apr; 108(4):634-8. PubMed ID: 13668796
    [No Abstract]   [Full Text] [Related]  

  • 40. Sixty years of follow-up of Hiroshima and Nagasaki survivors: current progress in molecular epidemiology studies.
    Nakachi K; Hayashi T; Hamatani K; Eguchi H; Kusunoki Y
    Mutat Res; 2008; 659(1-2):109-17. PubMed ID: 18406659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.